Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 59Carcinoma, Hepatocellular 46Colorectal Neoplasms 33Stomach Neoplasms 31Esophageal Squamous Cell Carcinoma 27Squamous Cell Carcinoma of Head and Neck 20Esophageal Neoplasms 14Small Cell Lung Carcinoma 13Neoplasm Metastasis 13Lung Neoplasms 13Rectal Neoplasms 12Head and Neck Neoplasms 12Advanced Solid Tumor 12Triple Negative Breast Neoplasms 11Nasopharyngeal Carcinoma 10Cholangiocarcinoma 10Uterine Cervical Neoplasms 9Recurrence 9Neoplasms 9Melanoma 9Colonic Neoplasms 9Pancreatic Neoplasms 7Urinary Bladder Neoplasms 6Solid Tumor 6Carcinoma, Transitional Cell 6Breast Neoplasms 6Sarcoma 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma 5Hodgkin Disease 5

Interventions

Radiotherapy 3Cisplatin 3Fluorouracil 2tislelizumab 1pembrolizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1TP protocol 1Spinal Puncture 1Rhenium 1Radiosurgery 1Poly I-C 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Gadolinium 1Folfox protocol 1Ethiodized Oil 1Erlotinib Hydrochloride 1Docetaxel 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1Anesthesia, General 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × tislelizumab × Clear all
NCT06441110 2024-06-04

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Fujian Medical University Union Hospital

Phase 3 Recruiting
76 enrolled
Genitourinary

Urinary Bladder Neoplasms, Motor Activity, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡